Agoracom Blog

Two New Buy Recommendations For Model Portfolio

Posted by Peter Grandich at 9:00 AM on Wednesday, April 29th, 2009

I’m adding two new buy recommendations to my model portfolio this monring:

Intel (INTC-NYSE) Buy at $15.25 or lower

Taseko Mines (TGB-ALNET) Buy at $1.40 or under

They must trade at or below my recommended price in order to be placed in the portfolio.

7 Responses to “Two New Buy Recommendations For Model Portfolio”

  1. Terry says:

    APH-V (Alda Pharmaceuticals) is introducing it’s new line of products tomorrow at the Ontario Dental Association convention in Toronto. This company and their products is a sleeper in my opinion. Please do your own DD here. All the best.

  2. Peter Grandich says:

    both new recommendations are on list Intc $15.17 TGB $1.39

  3. Peter Grandich says:

    correction $15.20 TGB $1.40

  4. susan says:

    You may also want to take a look at TC, a moly mine that has been moving up in price and really significant buying volumes. On friday, it moved up $.37 with 92% volume increase, Monday up $.72 with volume increase of 241% and Tuesday, up $.06 with 124% volume increase. So far today at 10:00 its up $.37 with above the average volume. Seems like institutions buying or something else going on. If someone else checks out this stock, would appreciate hearing any thoughts.

    Good luck to all….and thanks Peter for the New recommends. The global strategist I often follow, Don Coxe believes the techs are probably going to be the only growth vehicle for the US (in addition to agricuture).

  5. john says:

    Taseko Mines – tko.to

  6. Jacquie says:

    I like Taseko, and have followed it for a while. It’s also on my watchlist.

    Peter, have you heard of this company? It certainly would be a better alternative than vaccinations?
    From what I’ve read, it’s also effective against Swine flu, the Norwalk virus, HIV, Legionella, Polio and TB.

    ALDA PHARMACEUTICALS CORP – APH:TSX-V

    ALDA Pharmaceuticals Corp.-Bulletin: Swine Flu

    About ALDA Pharmaceuticals Corp.

    ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. T36(R) has been proven to be effective against the H1N1 and H3N2 strains of swine flu and against SARS-like viruses. The company trades on the TSX Venture Exchange under the symbol “APH”, and is quoted on the OTCBB under the symbol “APCSF”.

  7. Peter Grandich says:

    Don’t know ALDA

Leave a Reply